News Alert

Massachusetts 340B Measures Addressing PBM Discrimination and Medicaid Drug Coverage Fall Short in Senate, Sponsor Plans to Refile Bill Next Session

A contract pharmacy access bill could still pass in Massachusetts despite the end of the formal legislative session.
The Massachusetts Senate on Thursday failed to adopt legislation that would have prohibited pharmacy benefit managers (PBMs) from imposing discriminatory [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, Maryland

Federal district courts in Maryland and Mississippi saw various legal actions related to state 340B contract pharmacy access laws in the past week.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Massachusetts Senate to Vote on 340B PBM Nondiscrimination Measure; Status of Contract Pharmacy Bill Uncertain

Massachusetts lawmakers are expected to vote on Sen. Pavel Payano's (D) 340B PBM nondiscrimination bill Thursday.
Beacon Hill lawmakers are expected to vote Thursday on a proposal that would prohibit pharmacy benefit managers (PBMs) from imposing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GOP-Led House Appropriations Committee Votes to Cut HRSA Funding, Flat Funds OPA in Party Line Vote

The House Appropriations Committee approved the Labor, Health and Human Services, Education and Related Agencies Appropriations Act on July 10.
The House panel responsible for federal appropriations legislation passed a bill last week that would cut funding for the Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Study Finds Oncology Markups at 340B Pediatric Hospitals; AHA Slams Study and Funder 

New research looked at the prices 340B-enrolled pediatric hospitals charged for pediatric oncology drugs.
The rates 340B pediatric hospitals negotiate with payers for new pediatric oncology drugs often exceed a medication’s average sale price, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Matsui’s 340B PATIENTS Act Gains 5 Democratic Co-Sponsors Ahead of 340B Health Lobby Days

U.S. Capitol building at sunrise
Five congressional Democrats signed on as co-sponsors to a bill that would bar drugmaker restrictions on 340B contract pharmacy arrangements.
As hospital advocates prepared to begin their annual summer visits to Capitol Hill this week, five congressional Democrats signed on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Takes Issue with IRA’s Drug Negotiation Guidance

PhRMA recently urged CMS to establish a neutral clearinghouse and require accurate use of 340B claim modifiers to address nonduplication in its final guidance for Medicare drug price negotiations under the IRA.
Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Apotex to Issue Refunds to 340B Covered Entities 

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.
A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Providers Take Issue with CMS Draft Guidance on IRA Implementation Calling It “Problematic, Unworkable and Inconsistent”

340B provider groups strongly criticized the Centers for Medicare & Medicaid Services’ draft guidance for Medicare drug price negotiations.
Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Astellas Suspends its Contract Pharmacy Restrictions in More States; BMS and Sanofi Also Announce State Exemptions

Astellas building mounted sign
Astellas Pharma announced the suspension of its contract pharmacy policy in Maryland and Mississippi.
A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live